Share Buyback Transaction Details February 11 – 17, 2021
Share Buyback Transaction Details February 11 – 17, 2021
February 18, 2021 - Wolters Kluwer today reports that it has repurchased 99,235 of its own ordinary shares in the period from February 11, 2021, up to and including February 17, 2021, for
These repurchases are part of the share buyback program announced on October 30, 2020, under which we intend to repurchase shares for up to
The cumulative amounts repurchased to date under this program are as follows:
Share Buyback 2021
Period | Cumulative shares repurchased in period | Total consideration (€ million) | Average share price (€) |
2021 to date | 656,887 | 45.8 | 69.77 |
For the above-mentioned period, we have engaged a third party to execute
Repurchased shares are added to and held as treasury shares and will be used for capital reduction purposes or to meet obligations arising from share-based incentive plans.
Further information is available on our website:
- Download the share buyback transactions excel sheet for detailed individual transaction information.
- Weekly reports on the progress of our share repurchases.
- Overview of share buyback programs.
About Wolters Kluwer
Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the healthcare; tax and accounting; governance, risk and compliance; and legal and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.
Wolters Kluwer reported 2019 annual revenues of
Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt (ADR) program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
For more information, visit www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.
Media Investors/Analysts
Gerbert van Genderen Stort Meg Geldens
Corporate Communications Investor Relations
t + 31 172 641 230 t + 31 172 641 407